
At a Glance
248 Pages
24.77 x 17.78 x 1.91
Hardcover
$329.00
or 4 interest-free payments of $82.25 with
orShips in 5 to 7 business days
Industry Reviews
| Genetic Changes and Their Influence on Structure and Function of the Eye in Glaucoma | |
| Introduction | p. 1 |
| Glaucoma in Developmental Disorders | p. 2 |
| Development of the Ocular Mesenchyme in the Anterior Eye | p. 2 |
| Axenfeld-Rieger's Syndrome, Peters' Anomaly and Anterior Segment Dysgenesis | p. 4 |
| Aniridia | p. 9 |
| Primary Congenital Glaucoma | p. 11 |
| Nail-Patella Syndrome | p. 13 |
| Genes and Primary Open-Angle Glaucoma (POAG) | p. 13 |
| Loci for POAG | p. 14 |
| Myocilin | p. 15 |
| Optineurin | p. 19 |
| Genes and Pigmentary Glaucoma | p. 21 |
| References | p. 21 |
| Neuroprotection in Glaucoma | |
| Introduction | p. 29 |
| Basics | p. 29 |
| Rationale for Neuroprotection in Glaucoma | p. 30 |
| Necessary Steps for Neuroprotection | p. 31 |
| Preclinical Evidence for Neuroprotection in Glaucoma | p. 31 |
| NMDA Receptor Antagonists | p. 31 |
| 2-Adrenergic Receptor Agonists | p. 32 |
| ß1-Adrenergic Receptor Antagonists | p. 32 |
| Nitric Oxide Synthase Antagonists | p. 33 |
| Reactive Oxygen Species Scavengers and Lipid Peroxidation Inhibitors | p. 33 |
| Neurotrophic Factors | p. 33 |
| Vaccination | p. 34 |
| Clinical Experience with the Described Substances | p. 34 |
| Current Clinical Practice/Recommendations | p. 36 |
| References | p. 36 |
| Screening for Glaucoma | |
| Introduction | p. 39 |
| Why Screen for Glaucoma? | p. 40 |
| The Burden of Untreated Disease | p. 40 |
| The Importance of Early Detection | p. 41 |
| The Lack of Knowledge Regarding Glaucoma in the Lay Community | p. 41 |
| Current Screening Practices and Experience | p. 42 |
| Specific Screening Tests | p. 43 |
| Rationale for a Risk Factor Questionnaire | p. 43 |
| Frequency-Doubling Technology | p. 43 |
| Scanning Laser Polarimetry | p. 44 |
| The Promise of Teleophthalmology | p. 46 |
| The Cost-Effectiveness of Screening for Glaucoma | p. 46 |
| References | p. 49 |
| Semi-automated Kinetic Perimetry for Assessment of Advanced Glaucomatous Visual Field Loss | |
| Introduction | p. 51 |
| Methods/Methodological Aspects | p. 52 |
| Assessment and Definition of "Local Kinetic Threshold" and Local Scatter | p. 57 |
| Assessment and Importance of Individual Reaction Time | p. 57 |
| Selection of Optimum Target Angular Velocity | p. 58 |
| Age-Related Normative Values | p. 58 |
| Comparability of SKP Results with Those of Conventional Manual Kinetic Perimetry Using the GOLDMANN Instrument | p. 58 |
| Evaluation of Individual Functional Impairment/Expert Opinion | p. 59 |
| Training, Education and Learning | p. 59 |
| Outlook | p. 59 |
| References | p. 60 |
| Optic Nerve Imaging: Recent Advances | |
| Introduction | p. 63 |
| Background | p. 63 |
| Image Quality | p. 65 |
| Reproducibility | p. 66 |
| Detecting Glaucoma | p. 66 |
| Association Between Structure and Function | p. 66 |
| Detecting Change Over Time | p. 66 |
| Confocal Scanning Laser Ophthalmoscopy | p. 67 |
| Background | p. 67 |
| Image Quality | p. 71 |
| Reproducibility | p. 71 |
| Detecting Early to Moderate Glaucoma | p. 72 |
| Relationship Between Structure and Function | p. 72 |
| Detecting Change Over Time | p. 72 |
| Strengths and Limitations | p. 74 |
| Scanning Laser Polarimetry | p. 74 |
| Background | p. 74 |
| Image Quality | p. 76 |
| Reproducibility | p. 76 |
| Detecting Early to Moderate Glaucoma | p. 76 |
| Relationship Between Structure and Function | p. 78 |
| Detecting Change Over Time | p. 78 |
| Strngths and Limitations | p. 78 |
| Optical Coherence Tomography | p. 79 |
| Background | p. 79 |
| Image Quality | p. 81 |
| Reproducibility | p. 82 |
| Detecting Early to Moderate Glaucoma | p. 82 |
| Relationship Between Structure and Function | p. 83 |
| Detection of Longitudinal Change over Time | p. 84 |
| Strengths and Limitations | p. 85 |
| Scanning Retinal Thickness Analyzer | p. 85 |
| Background | p. 85 |
| Image Quality | p. 86 |
| Reproducibility | p. 86 |
| Discriminating Between Healthy Eyes and Eyes with Early to Moderate Glaucoma | p. 86 |
| Relationship Between Structure and Function | p. 86 |
| Detecting Change Over Time | p. 87 |
| Strengths and Limitations | p. 87 |
| Conclusions | p. 87 |
| References | p. 88 |
| New Concepts in the Diagnosis of Angle-Closure Glaucoma: The Role of Ultrasound Biomicroscopy | |
| Introduction | p. 93 |
| Ultrasound Biomicroscopy | p. 94 |
| The Normal Eye | p. 96 |
| Anatomical Classification of the Angle-Closure Glaucomas | p. 96 |
| Pupillary Block | p. 96 |
| Plateau Iris | p. 99 |
| Pseudoplateau Iris | p. 100 |
| Lens-Related Angle-Closure | p. 100 |
| Malignant Glaucoma | p. 102 |
| Conclusion | p. 103 |
| References | p. 103 |
| Childhood Glaucoma and Amblyopia | |
| Introduction | p. 105 |
| Patient Evaluation | p. 106 |
| Clinical Features | p. 106 |
| Examination Under Sedation | p. 106 |
| Examination Under Anesthesia (EUA) | p. 107 |
| Special Diagnostic Tests | p. 109 |
| Medical Management | p. 109 |
| Indications | p. 109 |
| Efficacy and Safety | p. 109 |
| Surgical Management | p. 110 |
| Goniotomy | p. 110 |
| Trabeculotomy | p. 111 |
| Trabeculectomy | p. 113 |
| Goniotomy versus Trabeculotomy versus Trabeculectomy versus Other Procedures | p. 115 |
| Glaucoma Drainage Implants | p. 117 |
| Cyclodestructive Procedures | p. 118 |
| Postoperative Management | p. 119 |
| Periodic Clinical Examination | p. 119 |
| Management of Amblyopia | p. 119 |
| Genetic Counseling | p. 121 |
| Conclusions | p. 121 |
| References | p. 122 |
| What Have We Learned from the Major Glaucoma Clinical Trials? | |
| Introduction | p. 125 |
| Advanced Glaucoma Intervention Study (AGIS) | p. 127 |
| Collaborative Normal Tension Glaucoma Study (CNTGS) | p. 129 |
| Collaborative Initial Glaucoma Treatment Study (CIGTS) | p. 130 |
| Ocular Hypertension Treatment Study (OHTS) | p. 131 |
| Early Manifest Glaucoma Trial (EMGT) | p. 135 |
| Conclusions | p. 136 |
| References | p. 136 |
| The Concept of Target IOP at Various Stages of Glaucoma | |
| Introduction | p. 139 |
| The Relationship Between IOP and the Risk of Visual Field Progression | p. 140 |
| Target Pressures in Glaucoma Management | p. 140 |
| Target Pressure | p. 140 |
| Randomized Controlled Trials and Target IOPs | p. 143 |
| References | p. 145 |
| A Practical Approach to the Management of Normal Tension Glaucoma | |
| Introduction | p. 147 |
| Background | p. 147 |
| Differential Diagnosis | p. 148 |
| Investigation | p. 151 |
| Investigation for the Purpose of Management | p. 152 |
| Management | p. 153 |
| References | p. 155 |
| Pseudoexfoliation Glaucoma | |
| Background | p. 157 |
| Pathobiology of PEX Syndrome | p. 158 |
| Pathogenesis | p. 158 |
| Pathogenetic Factors | p. 160 |
| Pathogenetic Concept | p. 160 |
| Etiology | p. 160 |
| Clinical Diagnosis | p. 161 |
| Manifest PEX Syndrome | p. 161 |
| Masked PEX Syndrome | p. 163 |
| Early Stages of PEX Syndrome | p. 164 |
| Asymmetry of Involvement | p. 164 |
| Differential Diagnosis | p. 164 |
| Open-Angle Glaucoma in PEX Syndrome | p. 165 |
| Epidemiology | p. 165 |
| Clinical Features | p. 165 |
| Pathomechanisms of Glaucoma Development | p. 166 |
| Acute Open-Angle Glaucoma | p. 170 |
| Angle-Closure Glaucoma in PEX Syndrome | p. 170 |
| Management | p. 171 |
| Medical Therapy | p. 172 |
| Laser Trabeculoplasty | p. 172 |
| Filtration Surgery | p. 172 |
| Summary and Perspectives | p. 173 |
| References | p. 174 |
| Pigment Dispersion Syndrome-Update 2003 | |
| Introduction | p. 177 |
| Clinical Findings | p. 177 |
| Anterior Segment | p. 177 |
| Posterior Segment | p. 179 |
| Pathophysiology | p. 179 |
| Developmental Abnormalities Underlying PDS | p. 181 |
| Blinking | p. 182 |
| Accommodation | p. 183 |
| Exercise | p. 183 |
| Clinical Correlations | p. 183 |
| Heredity | p. 183 |
| Gender | p. 183 |
| Race | p. 184 |
| Refractive Error | p. 184 |
| Asymmetric Involvement | p. 184 |
| Natural History | p. 184 |
| Active Phase | p. 184 |
| Regression Phase | p. 185 |
| Conversion to Glaucoma | p. 185 |
| Differential Diagnosis | p. 185 |
| Treatment | p. 186 |
| References | p. 188 |
| Wound Modulation in Glaucoma Surgery | |
| Introduction | p. 193 |
| Basics | p. 193 |
| Wound Healing Following Trabeculectomy | p. 193 |
| Therapeutic Options | p. 194 |
| Clinical Experience with the Described Substances | p. 196 |
| Corticosteroids | p. 196 |
| 5-Fluorouracil | p. 197 |
| Mitomycin | p. 199 |
| Transforming Growth Factor-ß | p. 205 |
| Suramin | p. 206 |
| Additional Substances | p. 206 |
| Current Clinical Practice/Recommendations | p. 206 |
| Post-operative Intensified Care | p. 207 |
| References | p. 207 |
| Non-penetrating vs Penetrating Surgery of Primary Open-Angle Glaucoma | |
| Introduction | p. 209 |
| Basics | p. 209 |
| Non-penetrating vs Penetrating Procedures: Clinical Evaluation | p. 211 |
| Efficacy | p. 211 |
| Safety | p. 212 |
| Affordability | p. 213 |
| Conclusions | p. 214 |
| References | p. 214 |
| Subject Index | p. 217 |
| Table of Contents provided by Publisher. All Rights Reserved. |
ISBN: 9783540406082
ISBN-10: 3540406085
Series: Essentials in Ophthalmology
Published: 25th May 2004
Format: Hardcover
Language: English
Number of Pages: 248
Audience: General Adult
Publisher: Springer Nature B.V.
Country of Publication: DE
Dimensions (cm): 24.77 x 17.78 x 1.91
Weight (kg): 0.65
Shipping
| Standard Shipping | Express Shipping | |
|---|---|---|
| Metro postcodes: | $9.99 | $14.95 |
| Regional postcodes: | $9.99 | $14.95 |
| Rural postcodes: | $9.99 | $14.95 |
Orders over $79.00 qualify for free shipping.
How to return your order
At Booktopia, we offer hassle-free returns in accordance with our returns policy. If you wish to return an item, please get in touch with Booktopia Customer Care.
Additional postage charges may be applicable.
Defective items
If there is a problem with any of the items received for your order then the Booktopia Customer Care team is ready to assist you.
For more info please visit our Help Centre.
You Can Find This Book In

Polit & Beck's Nursing Research
12th Edition - Generating and Assessing Evidence for Nursing Practice
Paperback
RRP $243.75
$135.75
OFF

Responsible Research Conduct
What Investigations into Alleged Research Misconduct Tell Us About Scientific Integrity
Hardcover
RRP $210.00
$184.75
OFF

Introduction to Teaching and Learning in the Health Professions
First Australian & New Zealand Edition
Paperback
RRP $113.00
$92.99
OFF





















